tiprankstipranks
Advertisement
Advertisement

ERAS Stock Latest News

Erasca upgraded to Neutral from Underperform at BofA
The FlyErasca upgraded to Neutral from Underperform at BofA
8d ago
ERAS
Adlai Nortye initiated with a Buy at JonesResearch
PremiumThe Fly
Adlai Nortye initiated with a Buy at JonesResearch
28d ago
ANL
ERAS
Erasca price target lowered to $26 from $28 at Mizuho
PremiumThe Fly
Erasca price target lowered to $26 from $28 at Mizuho
1M ago
ERAS
Analyst Reiterates Buy on ERAS-0015’s Emerging Pan-RAS Potential; $20 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on ERAS-0015’s Emerging Pan-RAS Potential; $20 Price Target Maintained
1M ago
ERAS
Erasca reports Q1 EPS (60c), consensus (23c)
PremiumThe Fly
Erasca reports Q1 EPS (60c), consensus (23c)
1M ago
ERAS
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe FlyMidday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
1M ago
BW
GM
Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
Premium
The Fly
Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
1M ago
MRK
ERAS
Erasca recent share selloff overdone, says JPMorgan
Premium
The Fly
Erasca recent share selloff overdone, says JPMorgan
1M ago
ERAS
H.C. Wainwright sees pressure for Erasca shares pending safety visibility
PremiumThe Fly
H.C. Wainwright sees pressure for Erasca shares pending safety visibility
1M ago
ERAS
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
PremiumThe Fly
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
1M ago
GM
KO
Erasca falls -52.6%
PremiumThe Fly
Erasca falls -52.6%
1M ago
ERAS
Erasca falls -46.0%
PremiumThe Fly
Erasca falls -46.0%
1M ago
ERAS
Unusually active option classes on open April 28th
PremiumThe FlyUnusually active option classes on open April 28th
1M ago
KO
ASX
Erasca falls after disclosing patient died after withdrawing from trial
Premium
The Fly
Erasca falls after disclosing patient died after withdrawing from trial
1M ago
ERAS
Erasca price target raised to $9 from $2 at BofA
Premium
The Fly
Erasca price target raised to $9 from $2 at BofA
1M ago
ERAS
RVMD
Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
PremiumRatings
Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
1M ago
ERAS
Closing Bell Movers: Sanmina jumps over 10% on earnings beat
PremiumThe Fly
Closing Bell Movers: Sanmina jumps over 10% on earnings beat
1M ago
CR
DG
Erasca Reports Encouraging Phase 1 Data for ERAS-0015
PremiumCompany Announcements
Erasca Reports Encouraging Phase 1 Data for ERAS-0015
2M ago
8K
ERAS
Erasca announces preliminary dose escalation data for ERAS-0015
PremiumThe Fly
Erasca announces preliminary dose escalation data for ERAS-0015
2M ago
ERAS
Erasca believes Revolution infringement claims ‘without merit,’ says Stifel
PremiumThe FlyErasca believes Revolution infringement claims ‘without merit,’ says Stifel
2M ago
ERAS
RVMD
Erasca falls -9.9%
Premium
The Fly
Erasca falls -9.9%
2M ago
ERAS
Erasca sinks after Revolution Medicines alleges patent infringement
Premium
The Fly
Erasca sinks after Revolution Medicines alleges patent infringement
2M ago
ERAS
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >